Page 11 - Embecta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oregon Public Employees Retirement Fund acquired a new position in Embecta Corp. (NASDAQ:EMBC – Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 19,083 shares of the company’s stock, valued at approximately $549,000. Several other institutional investors and hedge funds also recently bought […]

FREMONT, Calif. and PARSIPPANY, N.J., Nov. 07, 2022 -- Intuity Medical, Inc. and Embecta Corp. today announced they have signed a co-promotional agreement under which embecta sales... | November 7, 2022

Embecta (NASDAQ:EMBC – Get Rating) will be announcing its earnings results before the market opens on Monday, August 15th. Analysts expect the company to announce earnings of $0.87 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Embecta Trading Up 4.4 % Shares of […]

The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.